It is with great joy and pride that we share the remarkable journey of a 60-year-old female patient from Europe who battled glioblastoma multiforme (GBM) with unwavering strength and the revolutionary ECCT Treatment for GBM.
以极大的喜悦和自豪之情，我们分享了一位来自欧洲的60岁女性患者的卓越旅程，她以坚定的力量与革命性的ECCT治疗对抗多形性胶质母细胞瘤（GBM）。
Upon diagnosis of glioblastoma at her frontal lobe, the patient underwent surgery in February 2021. Subsequently, she embarked on an alternative treatment path, seeking a comprehensive approach to combat this aggressive form of brain cancer.
在额叶被诊断出多形性胶质母细胞瘤后，患者于2021年2月接受了手术。随后，她踏上了一条替代治疗之路，寻求一种全面的方法来对抗这种侵袭性的脑癌。In March 2021, a pivotal moment unfolded as the patient commenced radiotherapy concurrently with temozolomide. Following this, ECCT was introduced into her treatment plan by her oncology, incorporating Telozolamide for the past two years. The impact of ECCT has been nothing short of extraordinary, leading to a significant reduction in the size of bilateral giant tumors over this period.
在2021年3月，一个关键时刻展现出来，患者开始了与替莫唑胺同步的放疗治疗。此后，她的肿瘤科医生引入了ECCT治疗，整合了替莫唑胺，为过去两年的治疗。ECCT的影响丝毫不亚于非凡，导致了双侧巨大肿瘤在这段时间内显著减小。
After using ECCT with Telozolamide for three months, both clinically and radiologically, her oncology has observed a remarkable regression, signifying the efficacy and continued success of the ECCT treatment. The dedication and resilience demonstrated by her have been inspiring.
在使用ECCT与替莫唑胺治疗三个月后，临床和影像学上，她的肿瘤科医生观察到了显著的退化，标志着ECCT治疗的有效性和持续成功。她所展现的奉献和韧性令人鼓舞。Witnessing the transformative moment of her regaining her speech ability and memory, which was once compromised by the insidious effects of GBM. She has returned to normal now. Notably, the patient transitioned from tube feeding to oral intake, marking a significant improvement in her overall well-being.
看到她重新获得言语能力和记忆的转折时刻，这曾被GBM的隐匿影响所威胁。她现在已经恢复正常。值得注意的是，患者从管饲转为口服摄取，标志着她整体健康状况的显著改善。
As providers of ECCT, we are privileged to be part of this journey towards triumph over GBM. We extend our heartfelt congratulations to the patient for her courage and commitment. This success story reinforces our dedication to pushing the boundaries of medical innovation, bringing hope and healing to those facing the challenges of glioblastoma.
作为ECCT的团队，我们有幸成为这场战胜GBM的旅程的一部分。我们向患者表示衷心的祝贺，对她的勇气和承诺表示崇高的敬意。这个成功故事强化了我们推动医学创新边界、为面对多形性胶质母细胞瘤挑战的人们带来希望和康复的决心。
Comments